United States · FDA National Drug Code directory
Definity
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11994-011_8b5860ab-6714-4cf0-8679-f7c439fe5131
- Product NDC
- 11994-011
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- perflutren
- Labeler
- Lantheus Medical Imaging, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20010731
- Source listing expiry
- 20261231
Source-listed ingredients
- PERFLUTREN — 6.52 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (11994-011-01) / 1.5 mL in 1 VIAL, GLASS · 11994-011-01
- 4 VIAL, GLASS in 1 CARTON (11994-011-04) / 1.5 mL in 1 VIAL, GLASS · 11994-011-04
- 16 VIAL, GLASS in 1 CARTON (11994-011-16) / 1.5 mL in 1 VIAL, GLASS · 11994-011-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →